| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1993-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fab35b4bb9462102a9ed646f34fd5fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53c2c500c9ef279960c6eae91cc41e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e939b268ed34f1e5d3f10ca306018b07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e491c2bef03c38afd6c82058361c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7a156ba01f046a784eef19dd2c4c81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0020b8a7b26abf06370c8798bda8c25a |
| publicationDate |
2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100266554-B1 |
| titleOfInvention |
Recombinant anti-HIV antibody and preparation method thereof |
| abstract |
The present invention relates to a gene fragment encoding a variable region of an antibody having neutralizing activity against human immunodeficiency virus (HIV) and a method for producing the same. Rat-human hybrid antibodies and rat-human remodeling antibodies having neutralizing activity against HIV obtain specific nucleotide sequences of gene fragments encoding the H chain and L chain variable regions of the antibody having neutralizing activity against HIV. The DNA synthesized based on this nucleotide sequence can then be prepared by artificial fusion with a gene encoding human immunoglobulin. The novel recombinant anti-HIV antibodies of the invention are useful for the treatment and prevention of AIDS. |
| priorityDate |
1993-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |